EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hyperhomocysteinemia and Vitamin B Deficiency as Potential Aggravating Factors in Huntington's Disease: A Prospective Monocentric Study

Salomé Puisieux, Elise Pourié, Céline Bonnet iD, Lucie Hopes, Solène Frismand, Myriam Bronner, Virginie Roth, Marion Wandzel, Natacha Sloboda, Laetitia Lambert, Abderrahim Oussalah, Amélia Julien und 5 weitere

Movement Disorders · 2026-10 · 41 (10) · 2712-2722

DOI: 10.1002/mds.70413 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 01.07.2026. Verfasst von Salomé Puisieux und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital of Nancy, Nancy, France. Hauptthemen laut MEDLINE: Hyperhomocysteinemia, Huntington Disease, Vitamin B Deficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although not confirmed, some studies have suggested that elevated homocysteine levels are common in patients with Huntington's disease (HD). Its clinical relevance remains unclear.

Objectives

We aimed to assess vitamin B and homocysteine levels in HD patients and explore the relationships among hyperhomocysteinemia, vitamin B deficiency, and motor symptom progression.

Methods

In this monocentric case–control study, 77 HD patients were prospectively included between January 2020 and June 2023 at Nancy University Hospital. As controls, biological data were obtained retrospectively from 87 individuals referred to the Metabolic Medicine Department between January 2017 and February 2025. HD patients underwent clinical (Unified Huntington Disease Rating Scale‐Motor) and biochemical (vitamin B and homocysteine levels) evaluations. Fisher's exact test, Wilcoxon test, or Student's t‐test were used, with P < 0.05 considered significant.

Results

HD patients—both symptomatic and premanifest—had significantly higher homocysteine levels than did controls. Hyperhomocysteinemia was found in 36 patients (≈48%) and was associated with faster motor progression ( P < 0.001 ).

Conclusions

Hyperhomocysteinemia appears to be frequent in HD patients and may represent a risk factor contributing to phenotypic variability. These findings support a potential link between altered one‐carbon metabolism and HD. Further longitudinal and mechanistic studies are needed to clarify the clinical and pathophysiological relevance of homocysteine metabolism in HD and to determine whether targeting hyperhomocysteinemia could have therapeutic implications. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperhomocysteinemiaHuntington DiseaseVitamin B DeficiencyHumansFemaleMaleMiddle AgedHomocysteineCase-Control StudiesAdultProspective StudiesDisease Progression

Stichwörter der Autor:innen

Huntington's diseaseaggravating factorshomocysteinehyperhomocysteinemiaone‐carbon metabolismvitamin B deficiency

Substanzen

Homocysteine

Autor:innen und Institutionen

  • Department of Neurology, University Hospital of Nancy, Nancy, France.
  • INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, University of Lorraine, Nancy, France.
  • Laboratory Genetics, University Hospital of Nancy, Nancy, France.
  • Department of Clinical Neurogenetics, Hospital of Metz, F-57530 Ars-Laquenexy, France.
  • Department of Clinical Neurogenetics, University Hospital of Nancy, Nancy, France.
  • Medical Laboratory Reference Center for Inborn Errors of Metabolism (ORPHA67872), University Hospital of Nancy, Nancy, France.

ORCID-Profile: Céline Bonnet

Zitieren

APA

Puisieux, S., Pourié, E., Bonnet, C., Hopes, L., Frismand, S., Bronner, M., Roth, V., Wandzel, M., Sloboda, N., Lambert, L., Oussalah, A., Julien, A., Rotaru, I., Guéant-Rodriguez, R. M., Guéant, J. L., Bossenmeyer-Pourié, C., & Renaud, M. (2026). Hyperhomocysteinemia and Vitamin B Deficiency as Potential Aggravating Factors in Huntington's Disease: A Prospective Monocentric Study. Movement Disorders, 41(10), 2712-2722. https://doi.org/10.1002/mds.70413

Vancouver

Puisieux S, Pourié E, Bonnet C, Hopes L, Frismand S, Bronner M, et al. Hyperhomocysteinemia and Vitamin B Deficiency as Potential Aggravating Factors in Huntington's Disease: A Prospective Monocentric Study. Movement Disorders. 2026;41(10):2712-2722. doi:10.1002/mds.70413

BibTeX
@article{Puisieux2026,
  author = {Puisieux, Salomé and Pourié, Elise and Bonnet, Céline and Hopes, Lucie and Frismand, Solène and Bronner, Myriam and Roth, Virginie and Wandzel, Marion and Sloboda, Natacha and Lambert, Laetitia and Oussalah, Abderrahim and Julien, Amélia and Rotaru, Irina and Guéant-Rodriguez, Rosa-Maria and Guéant, Jean Louis and Bossenmeyer-Pourié, Carine and Renaud, Mathilde},
  title = {Hyperhomocysteinemia and Vitamin B Deficiency as Potential Aggravating Factors in Huntington's Disease: A Prospective Monocentric Study},
  journal = {Movement Disorders},
  year = {2026},
  volume = {41},
  number = {10},
  pages = {2712--2722},
  doi = {10.1002/mds.70413}
}
Kostenlos starten →